Senyo App for Addiction

Recruiting in Palo Alto (17 mi)

+1 other location

Overseen byTyler Oesterle

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Mayo Clinic

No Placebo Group

Trial Summary

What is the purpose of this trial?

The purpose of this study is to examine the barriers, facilitators, and optimal processes for implementing a digitally enhanced screening, brief intervention, and referral to treatment (SBIRT) model for Substance Use Disorder SUD treatment among Mayo primary care clinics.

Research Team

Tyler Oesterle

Principal Investigator

Mayo Clinic

Eligibility Criteria

This trial is for individuals with Substance Use Disorder (SUD) who are patients at Mayo primary care clinics. The study aims to understand how a digital tool can help in their treatment.

Inclusion Criteria

Ability to read, write, and understand English

Minimum DAST score of 1+ and audit-C score of 3+

Access and willingness to use a mobile device for asynchronous (text) and synchronous (video) engagement with care

Exclusion Criteria

I choose not to answer questions about thoughts of harming myself.

Diagnosed personality pathology as the primary presenting concern based on clinical judgment, severe cognitive impairment (e.g., intellectual disability or dementia), or psychosis

Inability to actively participate in and learn from psychotherapeutic interaction based on clinical evaluation and clinical judgment

See 1 more

Treatment Details

Interventions

Senyo App (Behavioral Intervention)

Trial OverviewThe trial is testing the 'Senyo App' against a waitlist control group, assessing its effectiveness in enhancing SUD treatment through screening and referrals within primary care settings.

Participant Groups

2Treatment groups

Experimental Treatment

Active Control

Group I: SenyoExperimental Treatment2 Interventions

Subjects randomized to the Senyo group will begin receiving intervention immediately, and will move to the follow-up phase after 12 weeks.

Group II: WaitlistActive Control2 Interventions

Subjects randomized to the waitlist group will serve as a control group and receive intervention after 12 weeks on the waitlist.